Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

LNCaP cells exposed to ceramic drug delivery treatment with epigallocatechin-3-gallate, thymoquinone, and tannic acid.

Richards LR, Jones P, Hughes J, Benghuzzi H, Tucci M.

Biomed Sci Instrum. 2007;43:242-7.

PMID:
17487088
2.

The physiological effect of conventional treatment with epigallocatechin-3-gallate, thymoquinone, and tannic acid on the LNCaP cell line.

Richards LR, Jones P, Hughes J, Benghuzzi H, Tucci M.

Biomed Sci Instrum. 2006;42:357-62.

PMID:
16817634
3.
5.

Cytotoxicity of epigallocatechin-3-gallate to LNCaP cells in the presence of Cu2+.

Yu HN, Shen SR, Xiong YK.

J Zhejiang Univ Sci B. 2005 Feb;6(2):125-31.

6.

Effects of (-)epigallocatechin gallate and thymoquinone on proliferation of a PANC-1 cell line in culture.

Tan M, Norwood A, May M, Tucci M, Benghuzzi H.

Biomed Sci Instrum. 2006;42:363-71.

PMID:
16817635
7.

Comparison of potential chemotherapeutic agents, 5-fluoruracil, green tea, and thymoquinone on colon cancer cells.

Norwood AA, Tan M, May M, Tucci M, Benghuzzi H.

Biomed Sci Instrum. 2006;42:350-6.

PMID:
16817633
8.

Anti-tumor effect of ascorbic acid, lysine, proline, arginine, and epigallocatechin gallate on prostate cancer cell lines PC-3, LNCaP, and DU145.

Roomi MW, Ivanov V, Kalinovsky T, Niedzwiecki A, Rath M.

Res Commun Mol Pathol Pharmacol. 2004;115-116:251-64.

PMID:
17564322
10.

Epigallocatechin gallate-loaded polysaccharide nanoparticles for prostate cancer chemoprevention.

Rocha S, Generalov R, Pereira Mdo C, Peres I, Juzenas P, Coelho MA.

Nanomedicine (Lond). 2011 Jan;6(1):79-87. doi: 10.2217/nnm.10.101.

PMID:
21182420
11.

The synergistic effect of conventional and sustained delivery of antioxidants on LNCaP prostate cancer cell line.

Richards LR, Benghuzzi H, Tucci M, Hughes J.

Biomed Sci Instrum. 2003;39:402-7.

PMID:
12724927
12.

Targeted biocompatible nanoparticles for the delivery of (-)-epigallocatechin 3-gallate to prostate cancer cells.

Sanna V, Pintus G, Roggio AM, Punzoni S, Posadino AM, Arca A, Marceddu S, Bandiera P, Uzzau S, Sechi M.

J Med Chem. 2011 Mar 10;54(5):1321-32. doi: 10.1021/jm1013715. Epub 2011 Feb 9.

PMID:
21306166
13.

Epigallocatechin-3-gallate affects the growth of LNCaP cells via membrane fluidity and distribution of cellular zinc.

Yang JG, Yu HN, Sun SL, Zhang LC, He GQ, Das UN, Ruan H, Shen SR.

J Zhejiang Univ Sci B. 2009 Jun;10(6):411-21. doi: 10.1631/jzus.B0820400.

14.

Green tea polyphenol, (-)-epigallocatechin-3-gallate, induces toxicity in human skin cancer cells by targeting ╬▓-catenin signaling.

Singh T, Katiyar SK.

Toxicol Appl Pharmacol. 2013 Dec 1;273(2):418-24. doi: 10.1016/j.taap.2013.09.021. Epub 2013 Oct 3.

15.

Taxol synergizes with antioxidants in inhibiting hormal refractory prostate cancer cell growth.

Ping SY, Hour TC, Lin SR, Yu DS.

Urol Oncol. 2010 Mar-Apr;28(2):170-9. doi: 10.1016/j.urolonc.2008.07.003. Epub 2008 Sep 24.

PMID:
18818108
16.

Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.

Thangapazham RL, Singh AK, Sharma A, Warren J, Gaddipati JP, Maheshwari RK.

Cancer Lett. 2007 Jan 8;245(1-2):232-41. Epub 2006 Mar 6.

PMID:
16519995
17.

Suppression of androgen receptor signaling and prostate specific antigen expression by (-)-epigallocatechin-3-gallate in different progression stages of LNCaP prostate cancer cells.

Chuu CP, Chen RY, Kokontis JM, Hiipakka RA, Liao S.

Cancer Lett. 2009 Mar 8;275(1):86-92. doi: 10.1016/j.canlet.2008.10.001. Epub 2008 Nov 1.

18.

Quercetin increased the antiproliferative activity of green tea polyphenol (-)-epigallocatechin gallate in prostate cancer cells.

Wang P, Heber D, Henning SM.

Nutr Cancer. 2012;64(4):580-7. doi: 10.1080/01635581.2012.661514. Epub 2012 Mar 27.

19.

Impact of Green Tea Catechin ECG and Its Synthesized Fluorinated Analogue on Prostate Cancer Cells and Stimulated Immunocompetent Cells.

Stadlbauer S, Steinborn C, Klemd A, Hattori F, Ohmori K, Suzuki K, Huber R, Wolf P, Gr├╝ndemann C.

Planta Med. 2018 Jul;84(11):813-819. doi: 10.1055/s-0044-102099. Epub 2018 Feb 21.

PMID:
29466808
20.

Oral administration of naturally occurring chitosan-based nanoformulated green tea polyphenol EGCG effectively inhibits prostate cancer cell growth in a xenograft model.

Khan N, Bharali DJ, Adhami VM, Siddiqui IA, Cui H, Shabana SM, Mousa SA, Mukhtar H.

Carcinogenesis. 2014 Feb;35(2):415-23. doi: 10.1093/carcin/bgt321. Epub 2013 Sep 26.

Supplemental Content

Support Center